Methods and compositions for diagnosing and treating, germline mismatch repair deficiencies, lynch syndrome and assessing germline risks of cancer
US-12331345-B2 · Jun 17, 2025 · US
Ostrer Harry is listed as an inventor on 13 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ostrer Harry |
| Total patents | 13 |
| First publication | Oct 19, 2017 |
| Latest publication | Jun 17, 2025 |
Publications ranked by popularity score, then publication date.
US-12331345-B2 · Jun 17, 2025 · US
US-12253524-B2 · Mar 18, 2025 · US
US-11981959-B2 · May 14, 2024 · US
US-2023258646-A1 · Aug 17, 2023 · US
US-11650206-B2 · May 16, 2023 · US
US-2022357319-A1 · Nov 10, 2022 · US
US-2022341935-A1 · Oct 27, 2022 · US
US-2022260553-A1 · Aug 18, 2022 · US
US-11397180-B2 · Jul 26, 2022 · US
US-2020309781-A1 · Oct 1, 2020 · US
Latest publications not already listed above.
US-10718774-B2 · Jul 21, 2020 · US
US-2018074049-A1 · Mar 15, 2018 · US
US-2017299600-A1 · Oct 19, 2017 · US
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Albert Einstein College Medicine | 8 |
| Albert Einstein College Medicine Inc | 7 |
| Morgan And Mendel Genomics Inc | 4 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| G01N33/5758 | 10 |
| C12Q1/6886 | 10 |
| G01N2800/50 | 10 |
| G01N33/57484 | 8 |
| G01N33/57545 | 6 |